Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

In 2010, after winning the British Airways Face of Opportunity grant, which provided ten free flight tickets to anywhere in ...

2Department of Pathology, University of Michigan, Ann Arbor, Michigan. 3Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan. Search for other works by this author on: 1Michigan Center for ...

Health care providers need to provide a careful explanation of the procedure, why it is being done, what the possible findings might be, as well as what follow-up care might be necessary.

5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma We performed a quality improvement study to evaluate our GT ...

In the US, Jemperli has already been approved for use in patients with dMMR/MSI-H advanced or recurrent endometrial cancer, both as a standalone therapy (monotherapy) or in combination with ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The management of advanced endometrial cancer has seen significant advancements in recent years, with several studies ...

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma In ... Collaborative Innovation Centre ...

and endometrial (uterine) cancer. Drinking alcohol not only damages your heart, kidney, and pancreas, but it can also put you at a grave risk of cancer. In fact its consumption is linked to an ...

Common early uterine cancer symptoms include atypical vaginal bleeding (including after menopause), unusual vaginal discharge, and pelvic pain. The condition is most common in females above 50 ...